![Arthur P. Bollon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arthur P. Bollon
Amministratore Delegato presso Vitruvian BioMedical, Inc.
Profilo
Arthur P.
Bollon was the founder of Biogress LLC (founded in 2003), Wadley Biosciences, Inc. (founded in 1987), Cytoclonal Pharmaceutics, Inc. (founded in 1992), and Vitruvian BioMedical, Inc. (founded in 2011) where he held the titles of Chairman & Chief Executive Officer.
He is currently an Independent Director at SignPath Pharma, Inc. (since 2008).
Dr. Bollon's former positions include President & Chief Executive Officer at Hemobiotech, Inc. (2003-2010) and Director at Immunotech Laboratories, Inc. He holds a doctorate degree from The Waksman Institute of Microbiology.
Posizioni attive di Arthur P. Bollon
Società | Posizione | Inizio |
---|---|---|
SignPath Pharma, Inc.
![]() SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Direttore/Membro del Consiglio | 28/05/2008 |
Vitruvian BioMedical, Inc.
![]() Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Amministratore Delegato | 01/01/2011 |
Precedenti posizioni note di Arthur P. Bollon
Società | Posizione | Fine |
---|---|---|
Hemobiotech, Inc.
![]() Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Amministratore Delegato | 01/08/2010 |
Cytoclonal Pharmaceutics, Inc. | Amministratore Delegato | 01/01/2000 |
Wadley Biosciences, Inc. | Amministratore Delegato | 01/01/1991 |
IMMUNOTECH LABORATORIES, INC. | Direttore/Membro del Consiglio | - |
Biogress LLC | Fondatore | - |
Formazione di Arthur P. Bollon
The Waksman Institute of Microbiology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
IMMUNOTECH LABORATORIES, INC. | Health Technology |
Aziende private | 6 |
---|---|
Hemobiotech, Inc.
![]() Hemobiotech, Inc. BiotechnologyHealth Technology HemoBioTech, Inc. is a biopharmaceutical company, that is engaged in the research and development of human blood substitute technology exclusively licensed from Texas Tech University Health Sciences Center. The company's core product, HemoTech, which is a bovine-hemoglobin based human blood substitute red blood cells in the capable of replacing human body. The company was founded in December 2003 and is headquartered in Dallas, TX. | Health Technology |
Biogress LLC | |
SignPath Pharma, Inc.
![]() SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | Commercial Services |
Cytoclonal Pharmaceutics, Inc. | Health Technology |
Wadley Biosciences, Inc. | |
Vitruvian BioMedical, Inc.
![]() Vitruvian BioMedical, Inc. Miscellaneous Commercial ServicesCommercial Services Vitruvian BioMedical, Inc. engages in the biotechnology industry. It develops and commercializes diagnostics and therapeutics for individualized and balanced healthcare with an initial focus on Alzheimer's Disease. The company was founded by Arthur P. Bollon, T. LaCarl Satcher and Rhonda R. Porterfield and is headquartered in Addison, TX. | Commercial Services |
- Borsa valori
- Insiders
- Arthur P. Bollon